ALLO
Allogene Therapeutics, Inc. · Healthcare
General Counsel Veer Bhavnagri sold $42K of Allogene Therapeutics, Inc.
Sold$42,186
$7.53Price
5,602Shares
−1%Stake
What ALLO did after the filing
- The stock from Mon, Dec 19 close, $6.50
- +26.3%
- S&P 500, same days
- +9.7%
Measured over 30 trading days, to the Feb 2 close.
Traded Thu, Dec 15. Filed Mon, Dec 19, 11:29 AM ET, during the session. Returns use the Dec 19 close and the Feb 2 close. Not investment advice.